These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26068762)

  • 21. Molecular abnormalities in pediatric barrett esophagus: can we test for potential of neoplastic progression?
    Maltby EL; Dyson MJ; Wheeler MR; Thomson M; Sethuraman C; Cohen MC
    Pediatr Dev Pathol; 2010; 13(4):310-7. PubMed ID: 20053129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of the serine/threonine protein kinase Akt during the progression of Barrett neoplasia.
    Sagatys E; Garrett CR; Boulware D; Kelley S; Malafa M; Cheng JQ; Sebti S; Coppola D
    Hum Pathol; 2007 Oct; 38(10):1526-31. PubMed ID: 17640711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
    Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
    Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barrett's: do we still need goblet cells for diagnosis?
    Lenglinger J; Riegler M
    Am J Gastroenterol; 2009 Sep; 104(9):2355-6; author reply 2356-7. PubMed ID: 19727095
    [No Abstract]   [Full Text] [Related]  

  • 25. Barrett esophagus and cancer: pathogenesis, carcinogenesis, and diagnostic dilemmas.
    Polkowski W; van Lanschot JJ; Offerhaus GJ
    Histol Histopathol; 1999 Jul; 14(3):927-44. PubMed ID: 10425562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the updated confocal laser endomicroscopy criteria for Barrett's esophagus among gastrointestinal pathologists.
    Tofteland N; Singh M; Gaddam S; Wani SB; Gupta N; Rastogi A; Bansal A; Kanakadandi V; McGregor DH; Ulusarac O; Cherian R; Mathur SC; Sharma P
    Dis Esophagus; 2014; 27(7):623-9. PubMed ID: 24006939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma.
    Wolfsen HC; Woodward TA; Raimondo M
    Mayo Clin Proc; 2002 Nov; 77(11):1176-81. PubMed ID: 12440553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin use and the risk of esophageal cancer in Barrett esophagus.
    Agrawal S; Patel P; Agrawal A; Makhijani N; Markert R; Deidrich W
    South Med J; 2014 Dec; 107(12):774-9. PubMed ID: 25502158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical treatment of Barrett's esophagus: 1980-2003.
    Csendes A
    World J Surg; 2004 Mar; 28(3):225-31. PubMed ID: 14961203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Barrett's oesophagus: from metaplasia to dysplasia and cancer.
    Fléjou JF
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i6-12. PubMed ID: 15711008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.
    Schneider PM; Stoeltzing O; Roth JA; Hoelscher AH; Wegerer S; Mizumoto S; Becker K; Dittler HJ; Fink U; Siewert JR
    Clin Cancer Res; 2000 Aug; 6(8):3153-8. PubMed ID: 10955797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining dysplasia in Barrett esophagus.
    Robert ME
    J Clin Gastroenterol; 2003; 36(5 Suppl):S19-25; discussion S26-8. PubMed ID: 12702961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent c-myc amplification in high-grade dysplasia and adenocarcinoma in Barrett esophagus.
    Sarbia M; Arjumand J; Wolter M; Reifenberger G; Heep H; Gabbert HE
    Am J Clin Pathol; 2001 Jun; 115(6):835-40. PubMed ID: 11392879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of MicroRNAs in the progression of barrett esophagus to adenocarcinoma in a long-term follow-up study.
    Revilla-Nuin B; Parrilla P; Lozano JJ; de Haro LF; Ortiz A; Martínez C; Munitiz V; de Angulo DR; Bermejo J; Molina J; Cayuela ML; Yélamos J
    Ann Surg; 2013 May; 257(5):886-93. PubMed ID: 23059500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia.
    Pouw RE; Gondrie JJ; Rygiel AM; Sondermeijer CM; ten Kate FJ; Odze RD; Vieth M; Krishnadath KK; Bergman JJ
    Am J Gastroenterol; 2009 Jun; 104(6):1366-73. PubMed ID: 19491850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of claudin proteins in esophageal adenocarcinoma and its precursor lesions.
    Montgomery E; Mamelak AJ; Gibson M; Maitra A; Sheikh S; Amr SS; Yang S; Brock M; Forastiere A; Zhang S; Murphy KM; Berg KD
    Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):24-30. PubMed ID: 16540726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic esophagectomy in Barrett esophagus with high-grade dysplasia.
    Heitmiller RF
    Langenbecks Arch Surg; 2003 Apr; 388(2):83-7. PubMed ID: 12712340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Barrett mucosa and mucosal secretion: does histochemistry of mucins have a predictive value?].
    Diebold MD
    Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D29-30. PubMed ID: 8013778
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetic and Epigenetic Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma.
    Kaz AM; Grady WM; Stachler MD; Bass AJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):473-89. PubMed ID: 26021206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Base transitions at CpG dinucleotides in the p53 gene are common in esophageal adenocarcinoma.
    Gleeson CM; Sloan JM; McGuigan JA; Ritchie AJ; Russell SE
    Cancer Res; 1995 Aug; 55(15):3406-11. PubMed ID: 7614480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.